Riociguat
Riociguat (BAY 632521) is a soluble guanylate cyclase (sGC) stimulator used in research for severe pulmonary arterial hypertension. It induces vasodilation by enhancing cGMP signaling and is applied in both in vitro mechanistic studies and in vivo animal models of pulmonary hypertension.
Product Specifications
CAS Number
625115-55-1
Product Name Alternative
BAY632521, BAY-632521, BAY 632521, guanylate cyclase, Guanylatecyclase, Guanylate Cyclase, Guanylate cyclase, Inhibitor, inhibit, Riociguat
Field of Research
Pharmacology & Drug Discovery
Purity
99.28% (May vary between batches)
Solubility
Ethanol:< 1 mg/mL (insoluble or slightly soluble) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.73 mM) ; DMSO:40.83 mg/mL (96.66 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
COC (=O) N (C) c1c (N) nc (nc1N) -c1nn (Cc2ccccc2F) c2ncccc12
Molecular Formula
C20H19FN8O2
Molecular Weight
422.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP219141 200 Reactions
LOC286359 Human qPCR Primer Pair (NM_182600)
Sign In for Pricing
View Details 
BNC040857-500 1x 500 µL
WT1 (Wilm's Tumor 1) (WT1/857), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
